권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Desnick RJ, Ioannou YA, Eng CM. α-galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw- Hill;2001. p.3733-74. | 미소장 |
| 2 | Tanaka H, Adachi K, Yamashita Y, Toshima H, Koga Y. [Four cases of Fabry’s disease mimicking hypertrophic cardiomyopathy]. J Cardiol 1988;18:705-18. | 미소장 |
| 3 | Hypertrophic Cardiomyopathy | 소장 |
| 4 | Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease. ![]() |
미소장 |
| 5 | Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. ![]() |
미소장 |
| 6 | Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. ![]() |
미소장 |
| 7 | Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy ![]() |
미소장 |
| 8 | Prevalence of lysosomal storage disorders. ![]() |
미소장 |
| 9 | alpha-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease. ![]() |
미소장 |
| 10 | Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. ![]() |
미소장 |
| 11 | Tsakiris D, Simpson HK, Jones EH, Briggs JD, Elinder CG, Mendel S, Piccoli G, dos Santos JP, Tognoni G, Vanrenterghem Y, Valderrabano F. Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERAEDTA Registry. Nephrol Dial Transplant 1996;11 Suppl 7:4-20. | 미소장 |
| 12 | Patients with Fabry disease on dialysis in the United States. ![]() |
미소장 |
| 13 | Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype. ![]() |
미소장 |
| 14 | End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry ![]() |
미소장 |
| 15 | Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy ![]() |
미소장 |
| 16 | An atypical variant of Fabry's disease with manifestations confined to the myocardium. ![]() |
미소장 |
| 17 | Whybra C, Kampmann C, Willers I, Davies J, Winchester B, Kriegsmann J, Brühl K, Gal A, Bunge S, Beck M. Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 2001;24:715-24. | 미소장 |
| 18 | Renoprotection by enzyme replacement therapy. ![]() |
미소장 |
| 19 | Short-Term Efficacy of Enzyme Replacement Therapy in Korean Patients with Fabry Disease | 소장 |
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: 정기간행물실(524호) / 서가번호: 국내17
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.